Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication (WALK)
This study has been completed.
Study NCT00117650   Information provided by Genzyme, a Sanofi Company

First Received on June 30, 2005.   Last Updated on October 2, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial